lycorine has been researched along with Osteosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Fan, S; Huang, H; Jie, Z; Li, X; Ning, L; Pan, X; Qin, A; Wan, S; Wan, X; Wang, J; Xie, Z; Zhao, X | 1 |
Deng, X; Hu, H; Liang, Z; Liu, W; Shao, Z; Song, Q; Wang, B; Wang, S; Xing, X; Yang, W; Zhang, Y; Zhong, B; Zhou, Z; Zhu, J | 1 |
2 other study(ies) available for lycorine and Osteosarcoma
Article | Year |
---|---|
Lycorine Induces Apoptosis and G1 Phase Arrest Through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells In Vitro and In Vivo.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; G1 Phase; Humans; MAP Kinase Signaling System; Mice; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phenanthridines; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2020 |
Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy.
Topics: Amaryllidaceae Alkaloids; Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Folic Acid; Gold; Humans; Mice; Microscopy, Fluorescence; Mitochondria; Nanocomposites; Neoplasms; Osteosarcoma; Oxidative Stress; Phenanthridines; Reactive Oxygen Species; Silicon Dioxide | 2021 |